These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9507668)

  • 21. A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.
    Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2004 Feb; 47(4):859-70. PubMed ID: 14761188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
    Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
    J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
    J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one as CB1 cannabinoid receptor ligands: synthesis and pharmacological evaluation.
    Muccioli GG; Martin D; Scriba GK; Poppitz W; Poupaert JH; Wouters J; Lambert DM
    J Med Chem; 2005 Apr; 48(7):2509-17. PubMed ID: 15801840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
    J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain.
    Lee YS; Fernandes S; Kulkarani V; Mayorov A; Davis P; Ma SW; Brown K; Gillies RJ; Lai J; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4080-4. PubMed ID: 20547453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical cyclization in heterocycle synthesis. II. Total synthesis of (+/-)-anantine and (+/-)-isoanantine.
    Naito T; Honda Y; Bhavakul V; Yamaguchi S; Fujiwara A; Miyata O; Ninomiya I
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1932-9. PubMed ID: 9433762
    [No Abstract]   [Full Text] [Related]  

  • 30. [Derivatives of phenylbutyrates. 3. Synthesis of compounds with potential anti-inflammatory activity correlated to 3,3'-diphenyl-N,N'-dipyrrolidine-2,2'-dione].
    Cignarella G; Fontanella L; Aresi V; Testa E
    Farmaco Sci; 1968 Apr; 23(4):321-43. PubMed ID: 5680376
    [No Abstract]   [Full Text] [Related]  

  • 31. Control of chemoselectivity in Dieckmann ring closures leading to tetramic acids.
    Jeong YC; Anwar M; Nguyen TM; Tan BS; Chai CL; Moloney MG
    Org Biomol Chem; 2011 Oct; 9(19):6663-9. PubMed ID: 21845281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of new optically active 2-pyrrolidinones.
    Moutevelis-Minakakis P; Papavassilopoulou E; Mavromoustakos T
    Molecules; 2012 Dec; 18(1):50-73. PubMed ID: 23344188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imidazolidine ring closure of amino acid 4-carboethoxyphenylamides.
    Kwapiszewski W; Kolwas J
    Acta Pol Pharm; 1978; 35(1):29-32. PubMed ID: 565574
    [No Abstract]   [Full Text] [Related]  

  • 34. N-aminoalkylsuccinimides as local anaesthetics. II. 1,2,3,4-Tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-diones substituted in the aromatic nucleus.
    Sandberg R; Domeij KE; Stening G; Svensson S; Willman N; Akerman B
    Acta Pharm Suec; 1980; 17(4):169-76. PubMed ID: 7468236
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure-activity relationships in tetramic acids and their copper (II) complexes.
    Matsuo K; Kitaguchi I; Takata Y; Tanaka K
    Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2494-502. PubMed ID: 7428128
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis of ( )-versimide (methyl -(methylsuccinimido)acrylate) and related compounds.
    Brown AG; Smale TC
    J Chem Soc Perkin 1; 1972; 1():65-76. PubMed ID: 5065750
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis of 5-membered ring-type compounds as potential cholecystokinin receptor ligands.
    Pentassuglia G; Araldi GL; Donati D; Feriani A; Oliosi B; Pasquarello A; Ursini A
    Farmaco; 1997 Oct; 52(10):573-81. PubMed ID: 9507668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.